tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Nathan Rich, 25 are a SELL (22.73%), 46 are a BUY (41.82%), 39 are a HOLD (35.45%).
Analyst Nathan Rich works at GOLDMAN SACHS with a stock forecast success ratio of 66.39% fulfilled within 95.91 days on average.
Nathan Rich’s has documented 218 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AMRX, Amneal Pharmaceuticals, . Common Stock at 04-Mar-2024.
Analyst best performing recommendations are on OSCR (OSCAR HEALTH).
The best stock recommendation documented was for XRAY (DENTSPLY SIRONA) at 4/7/2020. The price target of $40 was fulfilled within 2 days with a profit of $3.53 (9.68%) receiving and performance score of 48.4.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
22
$1.01 (4.81%)
1 years 10 months 12 days ago
3/4 (75%)
$1.33 (6.43%)
299
Buy
21
$0.01 (0.05%)
26
1 years 10 months 30 days ago
0/4 (0%)
$0.3 (1.45%)
Hold
1 years 11 months 2 days ago
1/3 (33.33%)
$7.54 (38.75%)
337
Buy
21
$0.01 (0.05%)
1 years 11 months 2 days ago
1/2 (50%)
$1.3 (6.60%)
54
Hold
22
1 years 11 months 2 days ago
0/2 (0%)
$6.55 (42.39%)
Which stock is Nathan Rich is most bullish on?
Which stock is Nathan Rich is most reserved on?
What Year was the first public recommendation made by Nathan Rich?
